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Abstract
Henoch-Schonlein Vasculitis (HSV) is systemic small vessel vasculitis involving the skin, kidney,
joints, and gastrointestinal tract. The proportion of patients reported to have renal involvement
varies between 20% and 80%. Rapidly progressive glomerulonephritis (RPGN)is rare syndrome in
children, characterized by clinical features of glomerulonephritis (GN) and rapid loss of renal
function. We present a severe kidney involvement in a 14 year old boy with HSV in who is carring
MEFV mutation. A 14 year old boy had developed sudden onset of palpable purpuric rash on his
extensor surfaces of lower extremities. He had elevated an erythrocyte sedimentation rate (ESR)
(45 mm/h), C-reactive protein (3.74 mg/dl), serum urea 66 mg/dl, serum creatinine 1.8 mg/dl. Also,
he had hypocomplementemia. Antinuclear antibody, anti ds DNA, antineutrophil cytoplasmic
antibody, anticardiolipine antibodies were negative. Urinalysis revealed macroscopic hematuria and
proteinuria with a 24-h urinary protein excretion of 55 mg/m2/h. The renal biopsy specimen
showed crescentic and necrotizing glomerulonephritis. He had also M694V/E148Q compound
heterozygote mutation. Clinical symptoms and renal failure resolved with intermittant hemodialysis
and medical therapy.
Background
Henoch-Schönlein Vasculitis (HSV) is systemic small ves-
sel vasculitis involving the skin, kidney, joints, and gas-
trointestinal tract. The annual incidence of HSV is 22 per
100000. The pathogenesis of HSV remains unknown;
however, HSV is generally believed to be immune com-
plex-mediated disease characterized by the presence of
polymeric IgA1-containing immune complexes predomi-
nantly in dermal, gastrointestinal and glomeruler capillar-
ies [1,2].
The proportion of patients reported to have renal involve-
ment varies between 20% and 80% [3-5]. In 80% of chil-
dren with a urinary abnormality, the first abnormality is
detected within 4 weeks of onset of the illness [6]. Hema-
turia may occasionally be the initial feature. Common uri-
nary abnormalities are albuminuria and microscopic
hematuria. A smaller number of patients have macro-
scopic hematuria. Acute nephritic syndrome occurs in
more severe cases and may lead to nephrotic syndrome or
to renal insufficiency [6,7].
Rapidly progressive glomerulonephritis (RPGN) is rare
syndrome in children, characterized by clinical features of
glomerulonephritis (GN) and rapid loss of renal function
[8]. This clinical course may be seen in any form of GN
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including poststreptococcal glomerulonephritis, renal
vasculitis, HSV.
It has been reported that certain vasculitides such as HSV
and polyarteritis nodosa (PAN) are more frequent among
familial Mediterranean fever (FMF) patients [9-14].
We present a severe kidney involvement in a 14 year old
boy with HSV in who carries MEFV mutation.
Case presentation
A 14 year old boy was referred to hospital with 2 days his-
tory of back and calf pain. He had developed sudden
onset of palpable purpuric rash on his extensor surfaces of
lower extremities especially bilateral ankles on admission.
There was no history of recent drug exposure, immuniza-
tion, or upper respiratory tract infection. He denied recur-
rent attacks of abdominal pain and fever. Family history
for FMF was negative. Physical examination showed a
temperature of 38.3°C, respiratory rate of 48/min, pulse
rate 128/min. He was hypertensive at 140/100 mmHg. In
auscultation, lungs were clear and the heart sounds were
normal. Abdominal palpation was normal. There were
symmetric palpable purpuric rash on his lower extremi-
ties.
Laboratory tests showed an erythrocyte sedimentation
rate (ESR) of 45 mm/h (normal: <20 mm/h), C-reactive
protein of 3.74 mg/dl (normal: < 0.3 mg/dl), hemoglobin
10.7 g/dl, hematocrit 32.3%, white blood cell count
(WBC) 11900/mm3 with normal differential count, plate-
let count 340000/mm3, serum urea 66 mg/dl, serum cre-
atinine 1.8 mg/dl, albumine 3.5 g/dl, total cholesterol 106
mg/dl, triglycerides 57 mg/dl, calcium 8.7 mg/dl, sodium
140 mEq/L, potassium 4.7 mEq/L, chloride 107 mEq/L,
alanine aminotransferase 23 U/l, aspartate aminotrans-
ferase 16 U/l. Serum complement-3 (C3) and comple-
ment-4 (C4) were decreased (85.4 mg/dl, 6.6 mg/dl,
respectively). Serum immunglobulin (Ig) levels were nor-
mal. The anti-streptolysin – O titer was 100 Todd unit and
throat culture was negative for group A B-hemolytic strep-
tococcus. Antinuclear antibody, anti ds DNA, antineu-
trophil cytoplasmic antibody, anticardiolipine antibodies
were negative. Urinalysis revealed macroscopic hematuria
and proteinuria with a 24-h urinary protein excretion of
55 mg/m2/h. The fecal occult blood testing was positive.
Renal ultrasonography (US) showed increased echogenic-
ity (grade 2) in bilateral kidneys. A skin biopsy showed a
leucytoclastic vasculitis and deposition of IgA. Renal dop-
pler US was normal. Renal magnetic resonance angiogra-
phy (MRA) to rule out PAN revealed normal results. Based
on these clinical findings, the patient was diagnosed as
having HSV with renal, skin and probable gastrointestinal
tract involvement. A diagnosis of FMF was suspected
because of the absence of occult blood in the stool and
normal mesenteric MRA. Since there are reports of
increase frequency of MEFV mutation in patients with
HSV, we performed DNA analysis in our patient and
found that he was compound heterozygote, carrying
M694V/E148Q.
On the second day of hospitalization, He had periorbital
and pitting pretibial edema. Respiratory examination
revealed bibasilar crackles. His urine output decreased
from 1.1 to 0.6 cc/kg/h and serum urea and creatine levels
were increased (105 mg/dl, 3.5 mg/dl, respectively). We
showed that serum urea and creatinine levels in figure 1.
Echocardiography showed pericardial effusion (3 mm),
minimal mitral regurgitation and increased inferior vena
cava index and inferior vena cava collapsibility index.
Serum urea levels (A) and creatinine levels (B) Figure 1
Serum urea levels (A) and creatinine levels (B).
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The renal biopsy specimen consists of two portions of
renal cortex and medulla. Forty glomeruli and many arter-
ies are available for examination on multiple sections. The
glomeruli are not significantly enlarged. They show varia-
ble, mostly segmental, expansion of the mesangial matrix
associated with mild segmental mesangial hypercellular-
ity. 25–30% of 40 glomeruli show crescents and/or necro-
tizing lesions (figure 2). Another glomeruli show
neutrophilic infiltration five glomeruli are available for
examination by immunofluorescence. The mesangium
contains peripheral membranous granular deposits of IgG
(2+), IgA (3+), C3 (3+).
On the fifth day at hospitalization, hemodialysis was ini-
tiated for treatment of RPGN. Intravenous pulse meth-
lyprednisolone was given (30 mg/kg, six consecutive
days), followed by oral prednisolone and cyclophospha-
mide (2 mg/kg/day) for crescentic and necrotizing
glomerulonephritis, in addition to Colchicine for FMF.
Clinical symptoms and renal failure resolved with inter-
mittent hemodialysis therapy (total 20 cycles, twice a
week). On one and half month after hospitalization, his
abnormal serum and urinary findings resolved.
Discussion
Henoch-Schönlein Vasculitis (HSV) is the most common
vasculitis in childhood and is characterized by a systemic
leukocytoclastic angiitis, mainly affecting the small vessels
of the skin, joints, gastrointestinal tract, and kidneys.
Other organs, such as brain, lungs, and scrotum, may
occasionally be involved. HSV usually affects children
between the ages of 5 and 15 years, while it is rare in
adults and in infants [15,16].
Renal involvement has been reported to occur in 20–80%
of children with HSV; among these Henoch-Schönlein
nephritis patients, 1–7% would suffer from ESRD
[4,5,17]. It has been generally accepted that the long-term
outcome is determined by the severity of renal involve-
ment, diffuse crescentic nephritis being associated with
the worst outcome [18]. A small percentage of children
develop serious renal disease. Essentially, renal involve-
ment accounts for the major morbidity of the disease.
RPGN is clinical syndrome characterized by an acute
nephritic illness accompanied by a rapid loss of renal
function over days to weeks [19]. The histopathological
correlate is the presence of cresents involving 50% or
more glomeruli. RPGN may ocur in a number of condi-
tions including postinfectious GN and HSV [8,19,20].
We report a case of HSV complicated by RPGN. The pres-
ence of typical rash, severe nephritis and IgA deposits on
skin and kidney biopsy confirm the diagnosis of HSV. In
addition to the highly suggestive biopsy findings for HSV,
negative ANCA, normal renal doppler USG, normal Renal
MR angiography excluded the diagnosis of PAN.
The overall incidence of vasculitis in FMF patients is 1% of
PAN and 5% of HSP, and it is significantly higher in FMF
patients than in normal population [9-11,21,22].
The pathogenesis of vasculitis in patients with FMF is
unknown [23]. The occurrence of circulating immune
complexes in 50% of patients with FMF, complement
consumption, defective inhibition of complement activa-
tion and uncontrolled release of TNF during the attacks
have been described. Therefore an immune related mech-
anism has been suggested to be involved in the pathogen-
esis of FMF [24]. Immune mechanisms also play roles in
FMF-associated vasculitis [24]. It is interesting to note the
presence of immunoglobulins, complement C3 and
fibrinogen in the skin and kidney biopsies in some of our
patients.
FMF may predispose to HSV, PAN, and other forms of vas-
culitis, either by amplifying the inflammatory response to
a subclinical insult or by predisposing to immune-medi-
ated diseases as a consequence of immune regulations
associated with FMF [25]. Further investigations of the
inflammatory consequences of FMF may also help to elu-
cidate the pathogenesis of different types of vasculitis
[20].
We reported an HSV patient with RPGN whose severe
course may be affected by the presence of MEFV mutation.
Segmental, expansion of the mesangial matrix and epithelial  cells prolipheration and/or necrotizing lesions Figure 2
Segmental, expansion of the mesangial matrix and 
epithelial cells prolipheration and/or necrotizing 
lesions.
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We suggest that colchicine provide additive effect on his
therapy.
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